DIRECT COMPONENTSEst. 1998 · Bio-mechanical solutions Contact
Home / Company
Company

Since 1998, built on design and manufacturing.

Direct Components Inc. is a Southern California company that invents, protects and develops materials and devices. Our lineup spans target acquisition, survival systems, portable power, hemorrhage control, skin care and space.

Our approach

We start from the problem in the field, engineer the material, then protect it before we scale it.

Our products are designed around a few constant ideas: fewer parts, less weight, faster use and less risk for the person applying them.

That discipline came from decades of precision manufacturing. We now apply it to polymer science, building one platform that can serve many settings, and holding the intellectual property in the parent company so every application benefits from the same foundation.

What we believe in

Principles that shape every product.

Creativity

Disruptive technology and category improvement start with original thinking.

Integrity

We stand behind what we make and how we describe it.

Adaptability

Modular, multi-functional designs that adapt to the setting and the mission.

Collaboration

We co-create with the people in the field who need the solution most.

Results-driven

Products that save time, minimize the risk of injury and improve human performance.

Milestones

From components to a platform.

Dates and descriptions are drafted for owner review.

1998

Direct Components founded

The company begins as a design and precision-manufacturing business in Southern California.

2016

First skin-treatment patent issues

US 9,511,034 marks the start of the medical patent estate.

2017

Field evaluation

Samaritan is assessed by special-operations medical subject-matter experts during a joint combat-trauma evaluation.

2020–2022

Wound-treatment family grows

Kits, compositions and methods for wound treatment and their continuations issue to Direct Components Inc.

2025

Spine patent issues

US 12,357,471 covers treatment of spinal injury with a multifocal polymer, with adjusted expiry in 2043.

Today

Platform company

Samaritan leads a portfolio structured to add further technologies as they are cleared for publication.

Next step

Meet the team behind it.

Engineering, clinical, IP and field expertise in one leadership group.